- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01472133
Validation of Respiration Rate Algorithms
Continuous accurate unobtrusive respiratory rate monitoring may lead to improved patient outcomes, as respiratory rate is thought to be a sensitive marker of patient deterioration. Currently systems are not suitable for long term monitoring, particularly in ambulant patients as they are too restrictive. To ensure that our algorithms are suitable for use in a clinical context we need to demonstrate their performance not only in the optimal situation, healthy volunteers at rest, but also in more challenging situations such as where the person being monitored is moving and also in patients who have conditions which may affect their physiology in such a way that the accuracy of the respiration rate estimation may be affected.
No previous study has systematically tested algorithms deriving respiratory rate from either the ECG or the photoplethysmography (PPG) waveforms in a real -world setting.
The algorithms work by looking for changes in intervals between heartbeats and also changes in the sizes of the ECG and PPG waveforms, both of which may be caused by respiration. These changes tend to diminish with increasing age and also conditions which alter the chest movement and cardiac reflexes. Thus it is important to test our algorithms' accuracy in participants exhibiting these conditions. It is also important to ensure that the calculations of respiratory rate are accurate across a range of heart rates and respiratory rates. Our testing covers all these variables.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, SE1 7EH
- St Thomas' Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Young Healthy Volunteers
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged between 18 and 40 years old.
Older Healthy Volunteers
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 70 years or above.
Patients
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18-70 years old.
- Participant has one of the following conditions:
- Atrial fibrillation
- A permanent pacemaker that is continuously active
- Reduced chest wall movement
Exclusion Criteria:
Young Healthy Volunteers
- Any condition which might increase the risk of exercise testing
- Any history of ischaemic heart disease
- Any history of heart failure
- Any structural heart disease (eg: valvular lesions, hypertrophic obstructive cardiomyopathy)
- Any abnormalities on a resting ECG
- Deep vein thrombosis diagnosed within the last 6 months or under active treatment
- Uncontrolled hypertension (systolic blood pressure >220 mm Hg, diastolic >120 mm Hg)
- Aortic aneurysm
- Aortic or cardiovascular surgery within 6 months of recruitment
- A family history of sudden cardiac death, congenital arrhythmia syndromes or cardiomyopathy
- Autonomic dysfunction, either previously diagnosed or upon testing by the research team
- Any condition involving the brain or spinal cord
- Diabetes
- Alcohol consumption > 21 units/week for women and 28 units/week for men or a history of previous alcohol dependence.
- Acute kidney injury
- Chronic kidney disease stage 4 or 5
- Any condition causing hepatic dysfunction
- Presence of a permanent pacemaker (these participants would be eligible for the pacemaker group)
- Reduced chest wall movement (these participants would be eligible for the reduced chest movement group)
- Any acute infection requiring antibiotic treatment within 3 months of recruitment
- Any other surgery or illness requiring hospitalisation within 3 months of recruitment
- Currently taking any medication with the exception of analgesics or the oral contraceptive pill.
- Any wound or skin condition affecting the torso which may be affected by the application of adhesive ECG dots to the skin
- Pregnancy
- Inability to give informed consent
Older Healthy Volunteers
- Any diagnosed condition primarily affecting the cardiovascular or respiratory systems
- Symptomatic autonomic dysfunction
- Orthostatic hypotension
- Any condition involving the brain or spinal cord
- Diabetes
- Alcohol consumption > 21 units/week for women and 28 units/week for men or a history of previous alcohol dependence.
- Acute kidney injury
- Chronic kidney disease stage 4 or 5
- Any condition causing hepatic dysfunction
- Presence of a permanent pacemaker
- Chronic Obstructive Pulmonary Disease (COPD).
- Any muscular dystrophy
- Kyphosis
- Scoliosis
- Pectus excavatum
- Any disease involving the lungs or pleura
- Any acute infection requiring antibiotic treatment within 3 months of recruitment
- Any other surgery or illness requiring hospitalisation within 3 months of recruitment
- Currently taking any medication with the exception of analgesics or the oral contraceptive pill.
- Any wound or skin condition affecting the torso which may be affected by the application of adhesive ECG dots to the skin
- Pregnancy
- Inability to give informed consent
Patients
- Any infection which would require isolation or barrier nursing according to the hospital's infection control policy
- Any wound or skin condition affecting the torso which may be affected by the application of adhesive ECG dots to the skin
- Requirement for any form of artificial ventilatory support, including oxygen therapy
- More than one of the inclusion criteria. (ie: a patient may not have both atrial fibrillation and reduced chest wall movement and be eligible for this study)
- Inability to give informed consent
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Young Healthy Volunteers
Healthy volunteers under the age of 40
|
Recording of 12 lead ECG
Recording of lying and standing blood pressure
Recording of chest wall movement
Done during deep breathing and a valsalva manoeuvre
For 10 mins
Recording of ECG and Pulse oximeter waveform during exercise
|
Older healthy volunteers
Healthy volunteers over the age of 70
|
Recording of 12 lead ECG
Recording of lying and standing blood pressure
Recording of chest wall movement
Done during deep breathing and a valsalva manoeuvre
For 10 mins
|
Patients with atrial fibrillation
Patients with permanent AF
|
Recording of 12 lead ECG
Recording of lying and standing blood pressure
Recording of chest wall movement
Done during deep breathing and a valsalva manoeuvre
For 10 mins
|
Patients with a pacemaker
Patients who have an implanted pacemaker that is continually pacing
|
Recording of 12 lead ECG
Recording of lying and standing blood pressure
Recording of chest wall movement
Done during deep breathing and a valsalva manoeuvre
For 10 mins
|
Patients with restricted chest movement
Patients whose chest expansion is less than 2.5cm
|
Recording of 12 lead ECG
Recording of lying and standing blood pressure
Done during deep breathing and a valsalva manoeuvre
For 10 mins
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The coefficient of variation for each respiration rate algorithm
Time Frame: 5-6 months
|
The algorithms to be tested are: one which calculates respiration rate (RR) from ECG only, one which calculates RR from PPG only, one which calculates RR from simultaneous ECG and PPG |
5-6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The coefficient of variation for the respiration rate calculated from a second pulse oximeter
Time Frame: 5-6 months
|
Participants will wear two different PPG monitors to assess whether PPG monitors from different manufacturers introduce artefactual changes to the PPG morphology
|
5-6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Richard Beale, MBBS, FRCA, Guy's and St Thomas' Foundation Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 11/LO/1667
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Rate
-
ContinUse Biometrics Ltd.CompletedHeart Rate | Respiratory RateIsrael
-
University Hospital Southampton NHS Foundation...University of SouthamptonCompletedExercise | Heart Rate | Respiratory RateUnited Kingdom
-
KK Women's and Children's HospitalRenew GroupActive, not recruitingHeart Rate | Respiratory Rate | Vital SignSingapore
-
KK Women's and Children's HospitalRenew GroupCompletedHeart Rate | Respiratory Rate | Vital SignSingapore
-
MX LABS spółka z ograniczoną odpowiedzialnością...CompletedHeart Rate Variability | Heart Rate | Respiratory RatePoland
-
Medtronic - MITGCompleted
-
Heroic Faith Medical Science Co., Ltd.Elite BioMedical Consulting IncRecruiting
-
Rijnstate HospitalActive, not recruiting
-
ChroniSense Medical Ltd.Completed
-
Spire, Inc.Clinimark, LLCCompleted
Clinical Trials on Recording of 12 lead ECG
-
Apple Inc.Iqvia Pty LtdCompleted
-
Apple Inc.Iqvia Pty LtdCompleted
-
Huawei Device Co., LtdCompletedArrhythmias, CardiacChina
-
Murdoch Childrens Research InstituteRecruiting
-
Mayo ClinicNot yet recruitingHypertrophic Cardiomyopathy | Athlete HeartUnited States
-
Qompium NVCompleted
-
University Hospital, BordeauxRecruitingVentricular ArrhythmiasFrance
-
The Leeds Teaching Hospitals NHS TrustLeeds and York Partnership NHS Foundation TrustUnknownCardiovascular Diseases | Dementia | Mental Health DisorderUnited Kingdom
-
AliveCorRecruitingMyocardial Infarction | Ischemia | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Heart Failure | Heart AttackUnited States